Literature DB >> 7550596

A decrease in neural sialyltransferase activity in Alzheimer's disease.

T M Maguire1, K C Breen.   

Abstract

The activities of both a particulate and soluble form of the sialyltransferase enzyme have been examined in post-mortem brain samples from Alzheimer's disease patients and age-matched controls. There was a considerable decrease in the activity of both the soluble and membrane-bound forms of the enzyme in the frontal and temporal cortical lobes, although no change was observed in the hippocampus. There was, however, no change in activity of the Golgi marker enzyme thiamine pyrophosphatase. Therefore, it is suggested that the decrease in sialyltransferase enzyme activity may be a specific biochemical event associated with the AD-like neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550596     DOI: 10.1159/000106944

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  14 in total

1.  The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein.

Authors:  Sylvia Ullrich; Anna Münch; Stephanie Neumann; Elisabeth Kremmer; Jörg Tatzelt; Stefan F Lichtenthaler
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain.

Authors:  Sarah A Flowers; Oliver C Grant; Robert J Woods; G William Rebeck
Journal:  Glycobiology       Date:  2020-01-28       Impact factor: 4.313

4.  Removal of 106 amino acids from the N-terminus of UDP-GlcNAc: alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I does not inactivate the enzyme.

Authors:  M Sarkar; S Pagny; U Unligil; D Joziasse; J Mucha; J Glössl; H Schachter
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

5.  Evidence for a correlation between ambient cholesterol levels and soluble plasma sialyltransferase enzyme activity.

Authors:  T M Maguire; M F Ryan; K C Breen
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

Review 6.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 7.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

8.  N-Glycan Profile of Cerebrospinal Fluids from Alzheimer's Disease Patients Using Liquid Chromatography with Mass Spectrometry.

Authors:  Byeong Gwan Cho; Lucas Veillon; Yehia Mechref
Journal:  J Proteome Res       Date:  2019-09-16       Impact factor: 4.466

9.  Precursor ion scanning for detection and structural characterization of heterogeneous glycopeptide mixtures.

Authors:  Mark A Ritchie; Andrew C Gill; Michael J Deery; Kathryn Lilley
Journal:  J Am Soc Mass Spectrom       Date:  2002-09       Impact factor: 3.109

10.  Sunday Driver Mediates Multi-Compartment Golgi Outposts Defects Induced by Amyloid Precursor Protein.

Authors:  Qianqian Du; Jin Chang; Guo Cheng; Yinyin Zhao; Wei Zhou
Journal:  Front Neurosci       Date:  2021-06-01       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.